| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VCYT | Common Stock | Award | $0 | +13,466 | +18% | $0.000000 | 86,705 | 27 Feb 2025 | Direct | F1, F2 |
| transaction | VCYT | Common Stock | Tax liability | $236,880 | -7,000 | -8.1% | $33.84 | 79,705 | 27 Feb 2025 | Direct | F3 |
| transaction | VCYT | Common Stock | Tax liability | $286,944 | -8,255 | -10% | $34.76 | 71,450 | 02 Mar 2025 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 27, 2025, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein. |
| F2 | Includes 370 shares of common stock purchased on January 31, 2025 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. |
| F3 | Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale. |
| F4 | The reporting person is reporting the withholding of 726, 453, 743 and 6,333 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 1,429, 892, 1,463 and 12,470 Restricted Stock Units granted on February 28, 2022, August 5, 2022, March 6, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person. |